Federal Register / Vol. 65, No. 188 / Wednesday, September 27, 2000 / Notices 58093

Name of facility City State Requested OPO Designated

OPO

Copley Hospital ................................................................. Morrisville ............................ VI NYAP MAOB

Mercy Memorial Hospital .................................................. Urbana ................................. OH OHLC OHLP

IV. Keys to the OPO Codes

The keys to the acronyms used in the

listings to identify OPOs and their

addresses are as follows:

MAOB ........... New England Organ Bank,

One Gateway Center,

Newton, MA 02158.

NYAP ............ Center for Donation and

Transplant, 218 Great

Oaks Blvd, Albany, NY

12203.

OHLC ............ Life Connection of Ohio,

1545 Holland Road, Suite

C, Maumee, OH 43537–

1694.

OHLP ............ Lifeline of Ohio, 770

Kinnear Road, Suite 200,

Columbus, OH 43212.

V. Collection of Information

Requirements

Under the Paperwork Reduction Act

of 1995, we are required to provide 60-

day notice in the Federal Register and

solicit public comment before a

collection of information requirement is

submitted to the Office of Management

and Budget (OMB) for review and

approval. In order to fairly evaluate

whether an information collection

requirement should be approved by

OMB, section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995

requires that we solicit comment on the

following issues:

• The need for the information

collection and its usefulness in carrying

out the proper functions of our agency.

• The accuracy of our estimate of the

information collection burden.

• The quality, utility, and clarity of

the information to be collected.

• Recommendations to minimize the

information collection burden on the

affected public, through the use of

automated collection techniques or

other forms of information technology.

Section 486.316 states the

requirements for a Medicare or

Medicaid participating hospital to

request a waiver permitting the hospital

to have an agreement with an OPO other

than the OPO designated for the service

area in which the hospital is located.

The burden associated with these

requirements are currently approved

under OMB 0938–0688, HCFA–R–13,

Conditions of Coverage for Organ

Procurement Organizations, with an

expiration date of November 30, 2001.

Authority: Section 1138 of the Social

Security Act (42 U.S.C. 1320b–8).

(Catalog of Federal Domestic Assistance

Program No. 93.773, Medicare—Hospital

Insurance; Program No. 93.774 Medicare—

Supplementary Medical Insurance, and

Program No. 93.778, Medical Assistance

Program)

Dated: August 31, 2000.

Robert A. Berenson,

Director, Center for Health Plans and

Providers, Health Care Financing

Administration.

[FR Doc. 00–24820 Filed 9–26–00; 8:45 am]

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

White House Initiative on Asian

Americans and Pacific Islanders,

President’s Advisory Commission;

Notice of Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Public Law 92–463), announcement is

made of the following National

Advisory body scheduled to conduct a

public meeting by teleconference during

the month October 2000.

Name: President’s Advisory Commission

on Asian Americans and Pacific Islanders

(AAPIs).

Date and Time: October 11, 2000; 5 p.m.–

7 p.m. EST.

The President’s Advisory Commission on

AAPIs will conduct a public meeting by

teleconference on October 11, from 5 p.m. to

7 p.m. EST inclusive. The meeting is open to

the public; however, teleconference lines are

limited. Please call Mr. Tyson Nakashima,

(301) 443–2492, if you are interested in

participating in the call and to obtain the

dial-in number. Agenda items will include,

but will not be limited to: Approval of

September Commission meeting minutes;

reports from subcommittees; administrative

tasks; and deadlines.

The purpose of the Commission is to

advise the President on the issues facing

Asian Americans and Pacific Islanders

(AAPIs). Requests to address the Commission

should be made in writing and should

include the name, address, telephone number

and business or professional affiliation of the

interested party. Individuals or groups

addressing similar issues are encouraged to

combine comments and present through a

single representative. The allocation of time

for remarks may be adjusted to accommodate

the level of expressed interest. Written

requests should be faxed to (301) 443–0259.

Anyone who has interest in joining any

portion of the meeting or who requires

additional information about the Commission

should contact: Mr. Tyson Nakashima, Office

of the White House Initiative on AAPIs,

Parklawn Building, Room 10–42, 5600

Fishers Lane, Rockville, MD, 20857,

Telephone (301) 443–2492. Anyone who

requires special assistance, such as sign

language interpretation or other reasonable

accommodations, should contact Mr.

Nakashima no later than October 4, 2000.

Dated: September 21, 2000.

Jane M. Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–24845 Filed 9–26–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Shared

Pathology Informatics Network.

Date: October 30–31, 2000.

Time: 7 pm to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Ave, Bethesda, MD 20814.

Contact Person: Kenneth L. Bielat,

Scientific Review Administrator, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8043, Bethesda,

MD 20892, (301) 496–7576.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

58094 Federal Register / Vol. 65, No. 188 / Wednesday, September 27, 2000 / Notices

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24725 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Community Clinical Oncology Program.

Date: October 24, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Cancer Institute, 6130

Executive Boulevard, Conference Room H,

Rockville, MD 20852.

Contact Person: Timothy C. Meeker,

Scientific Review Administrator, Special

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, Room

8088, Rockville, MD 20852, 301/594–1279.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Minority

Based Community Clinical Oncology

Program.

Date: October 25, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Cancer Institute, 6130

Executive Boulevard, Conference Room H,

Rockville, MD 20852.

Contact Person: Timothy C. Meeker,

Scientific Review Administrator, Special

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, Room

8088, Rockville, MD 20852, 301/594–1279.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24726 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Review and

Analysis of Tobacco Industry Documents.

Date: October 13, 2000.

Time: 8:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Cancer Institute, 6130

Executive Blvd., Conference Room C,

Rockville, MD 20852.

Contact Person: Mary Jane Slesinski,

Scientific Review Administrator, Special

Review and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8045, Bethesda,

MD 20892, 301/594–1566.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24727 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Interdisciplinary Research Teams for

Molecular Target Assessment (Molecular

Biology Section).

Date: October 19–20, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Holiday Inn—Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Joyce C. Pegues, Scientific

Review Administrator, Special Review,

Referral, and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, Room

8084, Bethesda, MD 20892, 301/594–1286.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24728 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M